Bruise Treatment Market (Disease Type: Hematoma, Purpura, Petechiae, and Others; and Indication: Bleeding Disorder, Vitamin Deficiencies, Skin Injury, and Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Bruise Treatment market size was estimated at USD 312.4 million in 2021 and is expected to surpass around USD 545 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.20% during the forecast period 2022 to 2030.

Bruise Treatment Market Introduction

Bruise is a skin injury that results in discoloration of the skin. Bruises are more common in patients taking medication for thinning their blood. In case of an internal blood vessel injury, blood pools under the skin, causing discoloration. This is termed as a deep bruise. Bruises can occur from a fall, accident, sports injury, or medical procedure. Geriatric people are highly susceptible to bruises. Certain bleeding disorders can also cause excessive bruising. Bruises that occur easily, or for no apparent reason, could indicate a bleeding disorder, especially if the bruising is accompanied by frequent nosebleeds or bleeding gums.

Bruises can be difficult to treat, as the majority of the damage occurs beneath the skin's surface. Some home remedies, on the other hand, may be able to speed up healing, minimize their appearance, and prevent them from occurring in the first place.

Report Scope of the Bruise Treatment Market

 Increase in Popularity of Sports and Exercise to Drive Global Market

Intense exercise could result in sore muscles and even lead to the development of deep bruises around the affected muscles. Straining a muscle injures muscle tissue deep beneath the skin. Blood vessels could burst as a result, leaking blood into the surrounding area. If the bleeding is more than usual, the blood pools under the skin and causes a bruise.

Rise in Prevalence of Blood Disorders such as Hemophilia and Von Willebrand Disease

Bruising is one of the most frequent and typical symptoms of hemophilia. Bruises result from the bleeding of tiny blood vessels under the skin, and since hemophilia prevents the blood from clotting properly, even minor bumps can turn into significant bruises.

People of all racial and ethnic backgrounds could develop hemophilia. Hemophilia A affects one in every 5,000 to 10,000 males. One in every 25,000 to 30,000 males has hemophilia B, a rare condition. The severe form of hemophilia A affects 60% to 70% of patients, while the moderate form affects 15%. The other individuals have a mild hemophilia.

The most prevalent bleeding disorder, Von Willebrand disease (VWD), affects up to 1% of people in the U.S. This indicates that 3.2 million people in the country, or roughly one in every 100, are affected by the disease. Despite the fact that both men and women could suffer from VWD, women are more likely to experience symptoms because of heavy or unusual bleeding both during and after childbirth. The three types of VWD are type 1, type 2, and type 3.

Availability of Over-the-counter NSAIDs to treat Bruises Bolstering Anti-inflammatory Drugs Segment

In terms of treatment type, the anti-inflammatory segment is projected to dominate the global market, accounting for more than 60% share by 2031. Bruises could lead to inflammation. Over-the-counter anti-inflammatory medications are commonly used to treat such bruises. These medications are most effective when used immediately following an injury, before swelling develops. NSAIDs such as aspirin and ibuprofen (Advil, Motrin); blood thinners such as warfarin (Coumadin), clopidogrel (Plavix), and heparin, and steroids (prednisone) are some medications used to treat bruises.

Regional Outlook of Global Bruise Treatment Market

North America is projected to account for major share of the global bruise treatment market during the forecast period. The market in the region is anticipated to grow at a rapid pace in the next few years due to the increase in research & development activities. Rise in awareness and improved healthcare infrastructure can be ascribed to North America's large market share. Europe is expected to be the second largest market during the forecast period. The bruise treatment market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Large population, improved access to healthcare systems, and rise in awareness about bruise treatment contribute to the growth of the bruise treatment market in the region.

Analysis of Key Players in Global Bruise Treatment Market

The global bruise treatment market is consolidated, with the presence of small number of companies. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players. Arnicare Boiron, STADA, Bioderma, Zealous Health Private Limited, Pharmavite, LLC, Topix Pharmaceuticals, Inc., and TriDerma are the prominent players operating in the bruise treatment market.

Key Developments in Global Bruise Treatment Market

• In January 2022, Takeda Pharmaceutical Company Limited announced that VONVENDI had been approved by the U.S. Food and Drug Administration (FDA). VONVENDI is the first and only recombinant Von Willebrand factor (VWF) replacement therapy to reduce the frequency of bleeding episodes.
• In March 2017, Pharmavites Nature Made, a leading vitamin and supplement brand, announced new product launches including Nature Made Omega-3 with Xtra Absorb Technology; Immune Care; Dual Action Digestive Probiotic + Energy B12 Gummies, and Nature Made Adult Gummies Multi for Him Plus Omega-3s

Some of the prominent players in the Bruise Treatment Market include:

• Arnicare Boiron
• STADA
• Bioderma
• Zealous Health Private Limited
• Pharmavite, LLC
• Topix Pharmaceuticals, Inc.
• TriDerma
• Other prominent players

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Bruise Treatment market

• Disease Type
• Hematoma
• Purpura
• Petechiae
• Others
• Indication
• Bleeding Disorder
• Vitamin Deficiencies
• Skin Injury
• Others
• Treatment Type
• Anti-coagulant Drugs
• Anti-inflammatory Drugs
• End-user
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Bruise Treatment industry analysis from 2022 to 2030 to identify the prevailing Bruise Treatment industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Bruise Treatment industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Bruise Treatment industry trends, key players, market segments, application areas, and market growth strategies.